Skip to content

TSX™ Transseptal Needle 00884450451717Recalls & reported problems

Merit Medical Systems, Inc. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00884450451717), received between Nov 30, 2021 and Dec 12, 2023 — classified as 1 death, 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Cardiac Tamponade2
  • Arrhythmia1
  • Cardiac Arrest1
  • Cardiac Perforation1
  • Pericardial Effusion1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 12, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE ACCOUNT ALLEGES THAT POST-TRANSEPTAL PUNCTURE, DURING AN ABLATION PROCEDURE FOR ATRIAL TACHYCARDIA, PERICARDIAL EFFUSION WAS NOTED, AND CARDIAC PERFORATION COULD NOT BE RULED OUT. THE PHYSICIAN ADVANCED AN ICE CATHETER AND ORDERED AN ECHO STUDY TO CONFIRM THE EFFUSION WAS DEVELOPING. PERICARDIAL PERFORATION WAS RULED OUT AT THIS TIME. AN EMERGENT PERICARDIOCENTESIS [PC] WAS PERFORMED. DURING THE PC, THE PATIENT EXPERIENCED VENTRICULAR TACHYCARDIA [VT] ARRHYTHMIA SO THE PATIENT WAS SUCCESSFULLY DEFIBRILLATED TO NORMAL SINUS RHYTHM. POST PC DRAINAGE PLACEMENT, 700CC OF FLUID WAS SUCCESSFULLY REMOVED FROM THE PATIENT PERICARDIAL SPACE. THE PATIENT WAS RETURNED TO THE UNIT FOR OBSERVATION IN STABLE CONDITION.

    Patient problems: Arrhythmia; Pericardial Effusion

    MAUDE report 18313049 ↗
  • InjurySep 13, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE ACCOUNT ALLEGES THAT DURING THE EARLY STAGES OF THE PROCEDURE (VASCULAR ACCESS) A TRANS-ESOPHAGEAL-ECHOCARDIOGRAPHY (TEE) WAS PERFORMED AND A SMALL PERICARDIAL EFFUSION NOTED WHILST THE PATIENT WAS IN A HYPERTENSIVE STATE. THE DECISION WAS MADE BY THE TREATING CLINICIAN TO CONTINUE THE CASE USING THE TSX FIXED SHEATH AND TSX NEEDLE, ON WHICH THE OPERATOR WAS ALSO PROPERLY TRAINED. THE DEVICES WERE INSERTED IN ORDER TO PROBE THE INTRA-ATRIAL SEPTUM FOR A SUFFICIENT SPOT TO REACH THE LEFT ATRIUM. DURING THE PROBING, AN INCREASE OF THE FORMERLY MENTIONED PERICARDIAL EFFUSION WAS DETECTED IN THE TEE AND BEFORE THE PASSAGE OF THE SEPTUM OCCURRED A PERICARDIAL PUNCTURE WAS DEEMED NECESSARY BY THE CLINICIAN IN ORDER TO MITIGATE THE PROBLEM AND RETURN TO A STABLE STATE FOR THE PATIENT. AS PER THE IFU OF THE SYSTEM, THE CLINICIAN AS ADVISED THAT AN ELEVATED ACT <300SEC. HAD TO BE MAINTAINED DURING THE ENTIRE LEFT ATRIAL DWELL-TIME OF THE CATHETER AND THAT FAILURE TO DO SO COULD POTENTIALLY HAVE A NEGATIVE EFFECT ON THE PERICARDIAL TAMPONADE. THE CLINICIAN DECIDED TO MOVE FORWARD AND PERFORM THE TRANSSEPTAL PUNCTURE UNDER CONSTANT TEE SUPERVISION AND EXCHANGING THE TSX SHEATH FOR THE POL

    Patient problems: Cardiac Tamponade

    MAUDE report 17736019 ↗
  • DeathNov 30, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE ACCOUNT ALLEGES THAT DURING A LEFT ATRIAL APPENDAGE CLOSURE [LAAC] PROCEDURE THE OPERATING PHYSICIAN EXPERIENCED COMPLICATIONS WITH THE TRANSSEPTAL NEEDLE KIT AND STEERABLE SHEATH. IT IS ALLEGED THAT "DEVICE ISSUES" MAY HAVE CAUSED OR CONTRIBUTED TO PATIENT COMPLICATIONS DURING THE PROCEDURE. THE ACCOUNT ALLEGES THAT "THE ATTENDING PHYSICIAN NEEDED TO REPOSITION THE STEERABLE SHEATH REPEATEDLY THROUGHOUT THE PROCEDURE". THE PATIENT EXPERIENCED A POSSIBLE "LEAK" [PERICARDIAL EFFUSION] THAT MAY HAVE LED TO POSSIBLE CARDIAC TAMPONADE ON THE LEFT ATRIAL APPENDAGE SIDE. A CODE WAS ACTIVATED, AND HOSPITAL PROTOCOLS WERE INITIATED IN ATTEMPTS TO STABILIZE THE PATIENT. THE LAA CLOSURE DEVICE WAS SUCCESSFULLY DEPLOYED DURING THIS PROCEDURE. THE PATIENT EXPIRED ON (B)(6) 2021. NO ADDITIONAL INFORMATION ABOUT THIS EVENT HAS BEEN PROVIDED TO MERIT MEDICAL BY THE ACCOUNT. A GOOD FAITH EFFORT OF 3 OR MORE ATTEMPTS TO COLLECT ADDITIONAL INFORMATION REGARDING THIS EVENT HAS BEEN SUCCESSFULLY COMPLETED BY THE MANUFACTURER IN A TIMELY MANNER.

    Patient problems: Cardiac Arrest; Cardiac Perforation; Cardiac Tamponade

    MAUDE report 12902241 ↗

Other Trocar devices

All Trocar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page